ImmunityBio, Inc. (IBRX) Earnings Call Transcripts

4 earnings calls from April 2024 to March 3, 2026

NasdaqGS US Health Care Biotechnology

About ImmunityBio, Inc.

ImmunityBio, Inc. (IBRX) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 4 calls on record spanning April 26, 2024 to March 3, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 4 ImmunityBio, Inc. earnings call transcripts on record, spanning April 26, 2024 to March 3, 2026. Based on this history, ImmunityBio, Inc. reports semi-annually. The most recent call on file is dated March 3, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
IBRX
Exchange
NasdaqGS
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
4
First call
April 26, 2024
Most recent
March 3, 2026
Reporting cadence
semi-annually
Quarter Date
Earnings Calls Mar 3, 2026 Read transcript
Company Conference Presentations Jan 12, 2026 Read transcript
Analyst/Investor Day Apr 15, 2025 Read transcript
Special Calls Apr 26, 2024 Read transcript